Comparison of the efficacy of first-line combinations for metastatic clear cell renal cell carcinoma: A propensity score-matched analysis of Japanese multicenter database

被引:0
|
作者
Yanagisawa, T. [1 ]
Mori, K. [1 ]
Fukuokaya, W. [1 ]
Kawada, T. [2 ]
Katayama, S. [2 ]
Uchimoto, T. [3 ]
Tsujino, T. [3 ]
Nishimura, K. [3 ]
Adachi, T. [4 ]
Toyoda, S. [5 ]
Komura, K. [3 ]
Takahara, K. [6 ]
Hashimoto, T. [4 ]
Fujita, K. [5 ]
Azuma, H. [3 ]
Ohno, Y. [4 ]
Shiroki, R. [6 ]
Uemura, H. [5 ]
Araki, M. [2 ]
Kimura, T. [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan
[2] Okayama Univ, Grad Sch Med, Dept Urol, Okayama, Japan
[3] Osaka Med & Pharmaceut Univ, Dept Urol, Osaka, Japan
[4] Tokyo Med Univ, Dept Urol, Tokyo, Japan
[5] Kindai Univ, Fac Med, Dept Urol, Osaka, Japan
[6] Fujita Hlth Univ, Sch Med, Dept Urol, Nagoya, Aichi, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0836
引用
收藏
页码:S1856 / S1857
页数:2
相关论文
共 50 条
  • [1] First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety
    Yanagisawa, Takafumi
    Mori, Keiichiro
    Kawada, Tatsushi
    Katayama, Satoshi
    Uchimoto, Taizo
    Tsujino, Takuya
    Nishimura, Kazuki
    Adachi, Takahiro
    Toyoda, Shingo
    Nukaya, Takuhisa
    Fukuokaya, Wataru
    Urabe, Fumihiko
    Murakami, Masaya
    Yamanoi, Tomoaki
    Bekku, Kensuke
    Komura, Kazumasa
    Takahara, Kiyoshi
    Hashimoto, Takeshi
    Fujita, Kazutoshi
    Azuma, Haruhito
    Ohno, Yoshio
    Shiroki, Ryoichi
    Uemura, Hirotsugu
    Araki, Motoo
    Kimura, Takahiro
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (11)
  • [2] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Yu-Wei Chen
    Brian I. Rini
    Current Oncology Reports, 2022, 24 : 695 - 702
  • [3] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Chen, Yu-Wei
    Rini, Brian, I
    CURRENT ONCOLOGY REPORTS, 2022, 24 (06) : 695 - 702
  • [4] Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis
    Chen, Zhen
    Wang, Kai
    Lu, Hao
    Xue, Dong
    Fan, Min
    Zhuang, Qianfeng
    Yin, Shuai
    He, Xiaozhou
    Xu, Renfang
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 909 - 919
  • [5] Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population
    Velho, Pedro Isaacsson
    Nardo, Mirella
    Leonardde Azevedo Souza, Manoel Carlos
    Colombo Bonadio, Renata R. C.
    Marta, Guilherrne Nader
    Muniz, David Q. B.
    Bastos, Diogo Assed
    Dzik, Carlos
    JOURNAL OF GLOBAL ONCOLOGY, 2018, 4
  • [6] Real-world comparison of first-line treatments for metastatic clear cell renal cell carcinoma (mccRCC)
    Yazdanpanah, Omid
    Dwabe, Sami
    Harada, Garrett
    Seyedin, Steven
    Mar, Nataliya
    CANCER RESEARCH, 2024, 84 (06)
  • [7] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [8] Prognostic value of preoperative fibrinogen in metastatic clear cell renal cell carcinoma patients undergoing cytoreductive nephrectomy: A propensity score-matched study.
    Shou, Jianzhong
    Cui, Honglei
    Bi, Xingang
    Guan, Youyan
    Shi, Hongzhe
    Zhou, Aiping
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [9] Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
    Atkins, Michael B.
    Tannir, Nizar M.
    CANCER TREATMENT REVIEWS, 2018, 70 : 127 - 137
  • [10] Safety and efficacy of tivozanib in first-line metastatic renal cell carcinoma: A multicenter compassionate use study
    Basso, Umberto
    Procopio, Giuseppe
    Fornarini, Giuseppe
    Massari, Francesco
    Bearz, Alessandra
    Fratino, Lucia
    Milella, Michele
    Bassanelli, Maria
    Sacco, Cosimo
    Bimbatti, Davide
    Verzoni, Elena
    Rizzo, Mimma
    Porta, Camillo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)